AKBA is a heavily shorted bio-technology company that recently won DOD funding for one of their phase three candidates. I think the bullish trend is just getting started and a real shove will add 100% or more to the price of the stock.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.